addiction
Adial Pharma Developing Regulatory Strategy for CDx Genetic Test for Alcohol Use Disorder Drug
Boudicca Dx will advise Adial Pharmaceuticals on its regulatory strategy for the genetic test, which it plans to use with its drug candidate AD04.
University at Buffalo-Led Team Explores Genetic Test to Predict Weight Loss After Bariatric Surgery
Premium
While the research is early stage, investigators so far have identified genetic variants predictive of sustained weight loss one year after surgery.
They are exploring a nicotine metabolite ratio that reflects variations in the CYP2A6 gene to gauge if it can ID patients who need more personalized smoking cessation interventions.
Proove Biosciences CEO Exonerated in PGx Test Kickback Case
Proove's founder and CEO was indicted last year on charges the company had defrauded Medicare and violated the Anti-Kickback Statute by paying physicians to use its pharmacogenetic tests.